At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
NO internventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hepatic Vein Flow Assessment With Transesophageal Echocardiography for Postoperative Graft Function Prediction in Orthotopic Liver Transplantation
In Brief
An observational study evaluating NO internvention for Postoperative Graft Function. Completed, enrolled 97 participants across 1 site.
Detailed Summary
Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure HVF using TEE and assess the correlation with postoperative graft function indices such as early allograft dysfunction(EAD), prolonged INR, platelet, and total bilirubin.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Graft Function
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedJan 2019
Primary CompletionDec 2019
TodayJul 2026
First PostedJan 23, 2019
Enrollment StartFeb 20, 2018
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.4 years ago
Interventions
NO internventionother
NO internvention